PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
11495816-4	2001	Produced from the 2-phenylaminopyrimidine class, a novel synthetic inhibitor, identified as CGP57148 (STI571), inhibits tyrosine kinase activity of c-ABL, BCR-ABL, PDGF-R and c-kit at micromolar concentrations.	serum sodium transport inhibitor	102-108	KIT proto-oncogene, receptor tyrosine kinase	Homo sapiens	175-180	
11423669-1	2001	Therapeutic agent STI571 (signal transduction inhibitor number 571) is a rationally developed, potent, and selective inhibitor for abl tyrosine kinases, including bcr-abl, as well c-kit and the platelet-derived growth factor receptor tyrosine kinases.	serum sodium transport inhibitor	18-24	KIT proto-oncogene, receptor tyrosine kinase	Homo sapiens	180-185